Literature DB >> 19264770

NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.

Laurie T Krug1, Christopher M Collins, Lisa M Gargano, Samuel H Speck.   

Abstract

NF-kappaB signaling is critical to the survival and transformation of cells infected by the human gammaherpesviruses Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. Here we have examined how elimination of the NF-kappaB transcription factor p50 from mice affects the life cycle of murine gammaherpesvirus 68 (MHV68). Notably, mice lacking p50 in every cell type were unable to establish a sufficiently robust immune response to control MHV68 infection, leading to high levels of latently infected B cells detected in the spleen and persistent virus replication in the lungs. The latter correlated with very low levels of virus-specific immunoglobulin G (IgG) in the infected p50(-/-) mice at day 48 postinfection. Because the confounding impact of the loss of p50 on the host response to MHV68 infection prevented a direct analysis of the role of this NF-kappaB family member on MHV68 latency in B cells, we generated and infected mixed p50(+/+)/p50(-/-) bone marrow chimeric mice. We show that the chimeric mice were able to control acute virus replication and exhibited normal levels of virus-specific IgG at 3 months postinfection, indicating the induction of a normal host immune response to MHV68 infection. However, in p50(+/+)/p50(-/-) chimeric mice the p50(-/-) B cells exhibited a significant defect compared to p50(+/+) B cells in supporting MHV68 latency. In addition to identifying a role for p50 in the establishment of latency, we determined that the absence of p50 in a subset of the hematopoietic compartment led to persistent virus replication in the lungs of the chimeric mice, providing evidence that p50 is required for controlling virus reactivation. Taken together, these data demonstrate that p50 is required for immune control by the host and has distinct tissue-dependent roles in the regulation of murine gammaherpesvirus latency during chronic infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264770      PMCID: PMC2682087          DOI: 10.1128/JVI.00111-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  91 in total

Review 1.  BAFF, APRIL and their receptors: structure, function and signaling.

Authors:  Claudia Bossen; Pascal Schneider
Journal:  Semin Immunol       Date:  2006-08-17       Impact factor: 11.130

2.  Cytokine production in the immune response to murine gammaherpesvirus 68.

Authors:  S R Sarawar; R D Cardin; J W Brooks; M Mehrpooya; R A Tripp; P C Doherty
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  NF-kappa B binds to the immunoglobulin S gamma 3 region in vivo during class switch recombination.

Authors:  Lili Wang; Robert Wuerffel; Amy L Kenter
Journal:  Eur J Immunol       Date:  2006-12       Impact factor: 5.532

4.  The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.

Authors:  Haihong Zhong; Michael J May; Eijiro Jimi; Sankar Ghosh
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

5.  Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.

Authors:  Sathish Sadagopan; Neelam Sharma-Walia; Mohanan Valiya Veettil; Hari Raghu; Ramu Sivakumar; Virginie Bottero; Bala Chandran
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

6.  BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

Authors:  Estefania Claudio; Keith Brown; Sun Park; Hongshan Wang; Ulrich Siebenlist
Journal:  Nat Immunol       Date:  2002-09-23       Impact factor: 25.606

7.  Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness.

Authors:  Cristen Pantano; Jennifer L Ather; John F Alcorn; Matthew E Poynter; Amy L Brown; Amy S Guala; Stacie L Beuschel; Gilman B Allen; Laurie A Whittaker; Mieke Bevelander; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

8.  Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo.

Authors:  Brigitte D de Lima; Janet S May; Sofia Marques; J Pedro Simas; Philip G Stevenson
Journal:  J Gen Virol       Date:  2005-01       Impact factor: 3.891

9.  Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes.

Authors:  Sofia Marques; Stacey Efstathiou; K G Smith; Matthias Haury; J Pedro Simas
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Lung epithelial cells are a major site of murine gammaherpesvirus persistence.

Authors:  J P Stewart; E J Usherwood; A Ross; H Dyson; T Nash
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  25 in total

1.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection.

Authors:  Michael S Nealy; Carrie B Coleman; Haiyan Li; Scott A Tibbetts
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

3.  Murine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture.

Authors:  Brandon Cieniewicz; Qiwen Dong; Gang Li; James C Forrest; Bryan C Mounce; Vera L Tarakanova; Adrianus van der Velden; Laurie T Krug
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

4.  A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.

Authors:  Brock G Bennion; Harshad Ingle; Teresa L Ai; Cathrine A Miner; Derek J Platt; Amber M Smith; Megan T Baldridge; Jonathan J Miner
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

5.  Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection.

Authors:  Joseph M Kulinski; Steven M Leonardo; Bryan C Mounce; Laurent Malherbe; Stephen B Gauld; Vera L Tarakanova
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

6.  Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis.

Authors:  Laurie T Krug; Edilson Torres-González; Qianhong Qin; Dan Sorescu; Mauricio Rojas; Arlene Stecenko; Samuel H Speck; Ana L Mora
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

7.  B Cell-Intrinsic SHP1 Expression Promotes the Gammaherpesvirus-Driven Germinal Center Response and the Establishment of Chronic Infection.

Authors:  K E Johnson; P T Lange; C N Jondle; P J Volberding; U M Lorenz; W Cui; B N Dittel; V L Tarakanova
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

8.  Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection.

Authors:  François Michaud; François Coulombe; Eric Gaudreault; Jasna Kriz; Jean Gosselin
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

9.  Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication.

Authors:  Xiaonan Dong; Hao Feng; Qinmiao Sun; Haiyan Li; Ting-Ting Wu; Ren Sun; Scott A Tibbetts; Zhijian J Chen; Pinghui Feng
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

10.  Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA.

Authors:  Brian S Wakeman; L Steven Johnson; Clinton R Paden; Kathleen S Gray; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.